
|Articles|August 1, 1999
Letters
Advertisement
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA issues complete response letter for sublingual epinephrine film Anaphylm
2
Pediatric respiratory infection patterns shift after COVID-19 pandemic
3
Steroid Safety, Growth Concerns, and When to Escalate Pediatric Therapy
4
AbbVie submits FDA, EMA applications for upadacitinib (RINVOQ) in non-segmental vitiligo for 12 years and older
5





